SOW
LUCD icon

State of Wyoming’s Lucid Diagnostics LUCD Stock Holding History

State of Wyoming’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
+93,927
New +$101K 0.01% 1396

Other funds holding LUCD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.37B AUM 28.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wyoming's LUCD Position: Q2 2026 in Review

State of Wyoming opened a new position in Lucid Diagnostics (LUCD) in Q2 2026: 93,927 shares worth $101K. The stake represents 0.01% of the portfolio and ranks #1396 among its holdings.

48 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • State of Wyoming held 93,927 shares of Lucid Diagnostics worth $101K as of Q2 2026.
  • Lucid Diagnostics was a new State of Wyoming position in Q2 2026.
  • Lucid Diagnostics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1396 holding.
  • 48 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.